Speaker illustration

Associate Professor Abderrahim Oulhaj

Khalifa University, Abu Dhabi (United Arab Emirates)

Dr. Abderrahim Oulhaj is an associate Professor in Biostatistics at the College of Medicine and Health Sciences, United Arab Emirates University. He holds a PhD in statistics from the UCL University, Belgium. He worked as a Senior Medical Statistician at the University of Oxford for almost 10 years. He was the lead medical statistician for the Oxford Project to Investigate Memory and Ageing (OPTIMA) and then moved to the Diabetes Trial Unit (DTU, Oxford University) to work as the lead medical statistician for the Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). Dr. Abderrahim Oulhaj divides his time in teaching undergraduate and post-graduate programs, supervising PhD and Master students and working on many research activities. His research include statistical modelling in the field of Diabetes, Cardio-vascular and Alzheimer’s diseases. He also has a strong interest in predictions modelling especially joint modelling of longitudinal markers and time to event.

The incorporation of repeated measurements of risk factors at current and previous visits improves the accuracy of cardiovascular risk assessment: an analysis of the EXSCEL trial

Event: ESC Preventive Cardiology 2023

Topic: Cardiovascular Risk Assessment, Other

Session: Moderated ePoster 22

Thumbnail

Sensitivity and specificity of cardiovascular risk thresholds used to guide treatment therapy

Event: EuroPrevent 2019

Topic: Cardiovascular Risk Assessment

Session: Risk Factors and Prevention – Cardiovascular Risk Assessment

Thumbnail

A new online application to assess and compare a multitude of cardiovascular risk prediction tools and prevention guidelines

Event: EuroPrevent 2019

Topic: Cardiovascular Risk Assessment

Session: Risk Factors and Prevention – Cardiovascular Risk Assessment

Thumbnail

Agreement between cardiovascular disease risk assessment tools in the arabian gulf countries population

Event: EuroPrevent 2018

Topic: Cardiovascular Risk Assessment

Session: Moderated Poster Session III

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb